SMTL ID : 6x0p.2 (3 other biounits)

Ash1L SET domain Q2265A mutant in complex with AS-5

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.69 Å

Oligo State

monomer

Ligands

1 x UK7: 3-[6-(aminomethyl)-1-(2-hydroxyethyl)-1H-indol-3-yl]benzene-1-carbothioamide(Non-covalent)

UK7.1: 16 residues within 4Å: Chain A: H.131, Y.132, C.133, Y.193, N.194, S.197, F.198, N.199, V.200, K.202, Q.204, I.216, I.217, G.218, G.219 Ligands: SAM.5 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:H.131, A:Y.193, A:N.199, A:V.200, A:I.217 Hydrogen bonds: A:C.133, A:F.198, A:F.198, A:G.218 Water bridges: A:I.217

3 x ZN: ZINC ION(Non-covalent)

ZN.2: 5 residues within 4Å: Chain A: C.29, C.31, C.42, C.46 Ligands: ZN.3 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.29, A:C.31, A:C.42, A:C.46 ZN.3: 5 residues within 4Å: Chain A: C.42, C.55, C.60, C.66 Ligands: ZN.2 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.42, A:C.55, A:C.60, A:C.66 ZN.4: 4 residues within 4Å: Chain A: C.158, C.206, C.208, C.213 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.158, A:C.206, A:C.208, A:C.213

1 x SAM: S-ADENOSYLMETHIONINE(Non-covalent)

SAM.5: 20 residues within 4Å: Chain A: K.88, G.89, W.90, S.129, D.130, H.131, Y.132, R.152, F.153, I.154, N.155, H.156, Y.193, Q.204, L.205, C.206, K.207, C.208, I.217 Ligands: UK7.1 12 PLIP interactions: 12 interactions with chain A Hydrogen bonds: A:W.90, A:H.131, A:Y.132, A:Y.132, A:N.155, A:N.155, A:H.156, A:H.156, A:Q.204, A:Q.204, A:K.207 Salt bridges: A:D.130

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Rogawski, D.S. et al., Discovery of first-in-class inhibitors of ASH1L histone methyltransferase with anti-leukemic activity. Nat Commun (2021)

Release Date

2021-04-07

Peptides

Histone-lysine N-methyltransferase ASH1L: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Histone-lysine N-methyltransferase ASH1L

Related Entries With Identical Sequence